FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Methotrexate Sodium Injection
Status: Resolved
»Duration of Shortage: 04/24/2017 - 12/17/2019
»Therapeutic Categories: Oncology

Expand all

Accord Healthcare Inc. (Revised 12/17/2019)

Company Contact Information:
800-843-7477

Presentation
  • 25 mg/mL; 2mL (NDC 16729-277-30)
  • 25 mg/mL; 40 mL (NDC 16729-277-35)
  • 25 mg/mL; 10 mL (NDC 16729-277-03)
Note:
  • N/A

Fresenius Kabi USA, LLC (Revised 12/17/2019)

Company Contact Information:
888-386-1300

Presentation
  • 1 gram per vial, 50 mL vial, SDV (NDC 63323-122-50)
  • 250 mg per 10 mL, vial (NDC 63323-123-10)
Note:
  • N/A

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 12/17/2019)

Company Contact Information:
800-631-2174

Presentation
  • 25 mg/mL, 2 mL vial (NDC 0143-9519-10)
Note:
  • N/A

Hospira, Inc. (Revised 12/17/2019)

Company Contact Information:
844-646-4398

Presentation
  • 50 mg/2 mL (25 mg/mL); Glass Fliptop Vial (NDC 61703-0350-38)
  • 1 g/40 mL (25 mg/mL); Single Dose Glass Fliptop Vial (NDC 61703-0408-41)
Note:
  • N/A

Mylan Institutional (Revised 12/17/2019)

Company Contact Information:
800-RXMYLAN (1-800-796- 9526)

Presentation
  • 1000 mg/40 mL (NDC 67457-480-40)
Note:
  • N/A

Teva Pharmaceuticals (Revised 12/17/2019)

Company Contact Information:
800-545-8800

Presentation
  • 25MG/ML 1X40ML (NDC 00703-3678-01)
  • 25MG/ML 1X40ML Premier label (NDC 00703-3678-81)
  • 25MG/ML 1X10ML (NDC 00703-3675-01)
  • 25MG/ML SDV 10X2ML (NDC 00703-3671-03)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English